Hyytiä H

ORCID: 0000-0002-8530-3654 · 1 paper in corpus

2020

Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125.

Communications biology ·doi:10.1038/s42003-020-01191-x

Cancer antigen 125 (CA125) is a widely used biomarker in monitoring of epithelial ovarian cancer (EOC). Due to insufficient cancer specificity of CA125, its diagnostic use is severely compromised. Abnormal glycosylation of CA125 is a unique…